Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysisAugust 15, 2022Lung CancerOncology
One in four NSCLC patients respond poorly to COVID-19 vaccineAugust 3, 2022Lung CancerOncologyCancerCOVID-19 Updates
Quality of life benefit exaggerated in some cancer studiesJuly 7, 2022OncologyBreast CancerGenitourinary CancerLung CancerMelanomaMixed TopicsRare Diseases
Cancer may increase risk of type 2 diabetesJuly 1, 2022Lung CancerBreast CancerGenitourinary CancerOncologyCancerDiabetes
Good chemo vs. bad chemo: When too much is a bad thingJune 28, 2022OncologyBreast CancerGenitourinary CancerLung CancerCancerOncology
My picks for best of ASCO 2022June 28, 2022Breast CancerGenitourinary CancerLung CancerOncologyCancer
Adjuvant vs. neoadjuvant? What has ASCO 2022 taught us regarding resectable NSCLC?June 27, 2022Lung CancerOncologyCancer
